share_log

锦艺集团控股(00565.HK)终止投资河北万玛生物医药有限公司

Jinyi Group Holdings (00565.HK) terminated investment in Hebei Wanma Biomedical Co., Ltd.

Gelonghui Finance ·  Jan 23 05:08

Gelonghui, January 23, 丨 Jinyi Group Holdings (00565.HK) announced that on October 3, 2023, Xufu Co., Ltd. (“Xufu”), an indirect wholly-owned subsidiary of the company, signed a non-legally binding letter of intent with Du Liudong (“founder shareholder”). Based on this, Xufu intends to invest in (but not limited to) Hebei Wanma Biomedical Co., Ltd. in the form of shares, loans or convertible bonds, and the founder shareholders intend to enter into a possible transaction with Xufu.

Since the parties have not entered into a formal agreement, the letter of intent terminates when three months from the date of the letter of intent expires.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment